<DOC>
	<DOCNO>NCT00767286</DOCNO>
	<brief_summary>RATIONALE : Patient abstract available PURPOSE : Patient abstract available</brief_summary>
	<brief_title>Goserelin , Flutamine , Radiation Therapy Treating Patients With Locally Advanced Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare locoregional control , disease-free survival , overall survival patient carcinoma prostate consider high risk relapse receive long-term adjuvant zoladex ( ZDX ) vs. adjuvant treatment follow neoadjuvant ZDX/flutamide radiotherapy . II . Compare sexual function patient treat two regimen . OUTLINE : Randomized study . Arm I : Neoadjuvant Antiandrogen Therapy Releasing Factor Agonist Therapy plus Radiotherapy . Flutamide , FLUT , NSC-147834 ; Zoladex , ZDX , NSC-606864 ; plus external-beam irradiation use megavoltage equipment energy least 4 MV ( least 6 MV prefer ) . Arm II : Neoadjuvant Antiandrogen Therapy Releasing Factor Agonist Therapy plus Radiotherapy follow Adjuvant Releasing Factor Agonist Therapy . FLUT ; ZDX ; plus external-beam irradiation use equipment Arm I ; follow ZDX . PROJECTED ACCRUAL : 1,508 patient accrue 2 year .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Flutamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm , locally advanced adenocarcinoma prostate , include : Bulky primary tumor confine prostate ( clinical Stage T2c ) Primary tumor extend beyond capsule ( clinical Stage T34 ) No common iliac paraaortic nodal involvement Regional lymph node involvement common iliac level allow Positive node image study must biopsied FNA surgical sampling PSA 150 ( mandatory ) No distant metastases PATIENT CHARACTERISTICS : Age : At least 50 Performance status : Karnofsky 70100 % Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior concurrent second cancer except basal cell skin cancer No major medical psychiatric illness would prevent completion treatment interfere followup PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : No prior hormonal therapy Radiotherapy : No prior radiotherapy Surgery : No prior radical surgery carcinoma prostate</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>